Patents by Inventor Guy Layton

Guy Layton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150196635
    Abstract: The present invention relates to compositions comprising peptides for preventing or treating allergy to birch, and in particular to optimal combinations of peptides for preventing or treating said allergy.
    Type: Application
    Filed: March 31, 2015
    Publication date: July 16, 2015
    Inventors: Roderick Peter HAFNER, Paul LAIDLER, Guy LAYTON, Mark LARCHE
  • Publication number: 20140302071
    Abstract: The present invention relates to compositions comprising peptides for preventing or treating allergy to house dust mites, and in particular to optimal combinations of peptides for preventing or treating said allergy.
    Type: Application
    Filed: May 19, 2014
    Publication date: October 9, 2014
    Inventors: Roderick Peter HAFNER, Paul LAIDLER, Guy LAYTON, Mark LARCHE
  • Publication number: 20120148612
    Abstract: The present invention relates to compositions comprising peptides for preventing or treating allergy to house dust mites, and in particular to optimal combinations of peptides for preventing or treating said allergy.
    Type: Application
    Filed: February 5, 2010
    Publication date: June 14, 2012
    Applicant: CIRCASSIA LIMITED
    Inventors: Roderick Peter Hafner, Paul Laidler, Guy Layton, Christopher Hugh Reginald Stocker, Mark Larche
  • Publication number: 20070049518
    Abstract: There is provided, inter alia, a method for the treatment or prevention of an inflammatory skin condition which is characterised by colonisation with Staphylococcus aureus, comprising the topical administration of an aureolysin inhibitor.
    Type: Application
    Filed: August 31, 2006
    Publication date: March 1, 2007
    Inventors: Stephen Chandler, Guy Layton
  • Publication number: 20040131598
    Abstract: The present invention relates to polynucleotides for use in cancer therapy. In particular, the invention provides a polynucleotide capable of expressing an epilope-&bgr;2m fusion protein; for use in the generation of cytotoxic T lymphocyte (CTL) responses against a tumour, and a polynucleotide capable of expressing an epitope-&bgr;2m fusion protein; for use in a method of restoring antigen presentation in the tumour of a host.
    Type: Application
    Filed: July 30, 2003
    Publication date: July 8, 2004
    Inventors: Sabrina Tafuro, Ute-Christiane Meier, Andrew James McMichael, John Irving Bell, Guy Layton, Michael Hunter